
Taiwania Capital is a Taiwanese venture capital firm founded in 2017 by the National Development Fund of the Executive Yuan and private enterprises. It manages multiple sector-focused funds investing in early to growth-stage technology and biotech startups across Taiwan, the U.S., Japan, and Southeast Asia.
They made 4 investments in the last 12 months. Average disclosed round size is $33.1M (across 25 rounds with reported amounts).
Portfolio
25
Fund Size
$200M
Top Stage
Series A
Last 12 Mo
4
Team
Hsin-Fu Huang, CFA
Managing Partner of SEA Fund
Ita Lu
Managing Partner of Tech / CEE Fund
Michael Huang
Managing Partner of Bio Fund
Richard Wang
Managing Partner of CEE / Tech Fund
Steven Lee
Managing Partner of Tech Fund
David Weng
CEO and General Partner of Tech / CEE / SEA Fund
Brian Wang
Investment Director
Gin Kao
Director of Legal Affairs
Andy Ho
Investment Principal
Bryan Kao
Investment Principal
Evan Lin
Investment Principal
Kate Chen
Investment Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| HHavoc | Series A | $100M | May 2026 |
| Ipo | — | May 2026 | |
| Series B | $50M | Apr 2026 | |
| Series A | $9.2M | Sep 2025 | |
| Series B | $10M | Jan 2024 | |
| Growth | $34M | Jan 2024 | |
| Unknown | $47M | Jan 2024 | |
| SSky Engine Ai | Series A | $7M | Jan 2024 |
| Seed | $6.5M | Nov 2023 | |
| Series A | $12M | Oct 2023 | |
| Series A | $13M | Mar 2023 | |
| Seed | $4.9M | Jan 2023 | |
| Series B | $40M | Jan 2023 | |
| PPavilion Data | Unknown | $45M | Jan 2022 |
| Series C | $88.5M | Nov 2021 | |
| Series B | $17M | Sep 2021 | |
| KKdan Mobile | Series B | $16M | Jul 2021 |
| Series A | — | Jun 2021 | |
| Series B | $55M | May 2021 | |
| Series B | $48.5M | Apr 2020 | |
| Series B | $14.5M | Feb 2020 | |
| RRegenacy Pharmaceuticals | Series A | $30M | Jan 2020 |
| Series A | $28M | Aug 2019 | |
| Series A | $40M | Nov 2018 | |
| Series A | — | — |
Top Co-Investors
Last updated: 8 September 2026